CTRI/2021/07/034929招募中未知
A prospective multi-centric randomized open label trial to assess efficacy of Hydroxychloroquine (HCQ) in reducing proteinuria in moderately severe primary IgA Nephropathy
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- one
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1.Adult patients(=18 years AND <60 years age) with biopsy proven primary IgA nephropathy
- •2.Persistent urinary protein creatinine ratio >1g/g but less than 3.5g/g
- •3.eGFR=45 ml/min/1.73m2 as calculated by the chronic kidney disease epidemiology collaboration creatinine equation (CKD-EPI)
- •4.Has been on ACEi/ARB therapy for at-least 6 months in maximal tolerated dose
排除标准
- •1.Use of immunosuppression in the past 6 months
- •2.IgAN requiring immunosuppression like crescentic IgAN or IgA vasculitis
- •3.Current or planned pregnancy or lactation
- •4.Concomitant systemic disease like diabetes, chronic liver disease, malignancy, any cardiac or cerebrovascular disease
- •5.Retinopathy
- •6.G6PD deficiency
- •7.Unwilling to give consent
研究者
相似试验
Unknown
3 期
A prospective open label, randomized, multi-centre, parallel design, controlled study to evaluate the efficacy and safety of DNANOPAURONA to treating castration resistant prostate cancerCTRI/2018/05/013553Dhanvantari Nano Ayushadi Private Limited
已完成
2 期
Biological E’s Polio vaccine clinical study for protection against Polio disease in 6-8 weeks old infants.CTRI/2023/08/055993Biological E.Limited120
招募中
4 期
Comparative study of effect of Remogliflozin and Empagliflozin on parameters of heart failure.CTRI/2020/11/029176Sengupta Hospital and Research Institute
已完成
3 期
A clinical trial to study the safety and efficacy of teriparatide in postmenopausal osteoporosisCTRI/2009/091/000190Cadila Healthcare Limited83
进行中（未招募）
1 期
A Study to Compare the Efficacy and Safety of a Combined Regimen of Obinutuzumab and Venetoclax (GDC-0199/ABT-199) Versus Obinutuzumab and Chlorambucil in Previously Untreated Patients with CLL and Coexisting Medical ConditionsCTIS2023-504034-22-00F. Hoffmann-La Roche AG397